Related Experiment Video
Updated: Jul 13, 2026

Unveiling Histone Proteoforms using 2D-TAU Gel Electrophoresis
Published on: October 18, 2024
Unraveling the epigenetic code of cancer for therapy
Laura T Smith1, Gregory A Otterson, Christoph Plass
1Division of Human Cancer Genetics, Department of Molecular Virology, Immunology and Medical Genetics, OH, USA.
Abstract:
Alterations in the genome and the epigenome are common in most cancers. Changes in epigenetic signatures, including aberrant DNA methylation and histone deacetylation, are among the most prevalent modifications in cancer and lead to dramatic changes in gene expression patterns. Because DNA methylation and histone deacetylation are reversible processes, they have become attractive as targets for cancer epigenetic therapy, both as single agents and as 'enhancing' agents for other treatment strategies. In this review we discuss our current view of the mammalian epigenome, this view has changed over the years because of the availability of novel technologies. We further demonstrate how the profound understanding of epigenetic alterations in cancer will help develop novel strategies for epigenetic therapies.
Insights
Cancer epigenetics involves DNA methylation and histone deacetylation, reversible processes targeted for therapy. Understanding these epigenetic alterations aids in developing novel cancer treatment strategies.
Area of Science:
- Oncology
- Epigenetics
- Molecular Biology
Background:
- Cancer is characterized by genomic and epigenomic alterations.
- Aberrant DNA methylation and histone deacetylation are prevalent epigenetic changes in cancer, altering gene expression.
- These epigenetic modifications are reversible, making them promising therapeutic targets.
Purpose of the Study:
- To review the current understanding of the mammalian epigenome.
- To discuss the role of epigenetic alterations in cancer development.
- To explore the potential of epigenetic therapies for cancer treatment.
Main Methods:
- Review of current literature on epigenetics and cancer.
- Analysis of technological advancements in epigenome research.
- Synthesis of knowledge on epigenetic modifications and their therapeutic implications.
Main Results:
- Epigenetic signatures, particularly DNA methylation and histone deacetylation, are key drivers of cancer gene expression changes.
- Novel technologies have significantly advanced our understanding of the epigenome.
- Epigenetic alterations in cancer present opportunities for targeted therapeutic interventions.
Conclusions:
- A profound understanding of cancer epigenetics is crucial for developing effective epigenetic therapies.
- Epigenetic therapies, targeting DNA methylation and histone deacetylation, offer promising avenues for cancer treatment.
- The reversibility of epigenetic modifications supports their role in novel cancer treatment strategies, potentially enhancing other therapies.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Epigenetic Regulation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
